The proportion of patients hitting meaningful thresholds tells an even more dramatic story
Then, level it off, like a plane coming into land
The TRANSCEND-T2D-1 trial adds a second pressure point: 16.8% body weight reduction in patients with type 2 diabetes, a population that consistently underperforms on weight-loss endpoints with existing agents
For analysis of erythroid progenitor cells, fetal liver cells were stained with PE-anti mouseTer119 (Biolegend, 116207, 1:200), PE/Cy7-anti CD44 (Biolegend, 103029, 1:200) and DAPI
When combined with dietary and lifestyle changes, it offers sustainable results
SGLT2 inhibitors might not cause EDKA by themselves but instead create a predisposition that can lead to the condition when certain triggering factors are present